Related references
Note: Only part of the references are listed.Aspirin for the Prevention of Cardiovascular Disease: U.S. Preventive Services Task Force Recommendation Statement
ANNALS OF INTERNAL MEDICINE (2013)
A new oral antiplatelet agent with potent antithrombotic properties: Comparison of DZ-697b with clopidogrel in a randomised phase I study
M. Urooj Zafar et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Aspirin for Prevention and Treatment of Cardiovascular Disease
Shamir R. Mehta
ANNALS OF INTERNAL MEDICINE (2009)
Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding
Steven R. Steinhubl et al.
ANNALS OF INTERNAL MEDICINE (2009)
Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina
F Cipollone et al.
CIRCULATION (2000)
The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice - Evidence that eicosanoids other than thromboxane contribute to atherosclerosis
AJ Cayatte et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
